- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Heart rate adjusted heart rate variability reliable predictor of risk of sudden cardiac death
A new study published in BMC Cardiovascular Disorders suggests that similar exponential decay relationships between heart rate variability (HRV) measurements and heart rate (HR) were seen in subjects with varying sudden cardiac death (SCD) risks, however at varied rates of decay.
The predictive utility of heart rate variability for risk stratification of sudden cardiac death is yet unknown. Heart rate variability is a non-invasive method for the evaluation of cardiovascular autonomic function. Su-Peng Yan and colleagues looked at the effectiveness of the heart rate adjusted HRV (HRVI) for SCD risk stratification in people with various risks.
A total of 192 participants, comprising 88 healthy controls (low risk group), 82 people with hypertrophic cardiomyopathy (HCM), and 22 people with SCD, had their HRV measures examined (high risk group). Both a long-term and short-term study was used to explore the connection between HRV measures and HR. AUC and covariance of variation were used to assess the HRVI's performance (CV).
The key findings of this study were:
While the exponential power coefficients varied widely between groups, the majority of HRV measures exponentially degraded as HR increased.
With a median AUC of 0.72[0.11], the HRVI measures distinguishing between patients at low, medium, and high risk.
This was a significant improvement over the standard long-term and short-term HRV without correction.
Compared to conventional short-term HRV measurements, the average CV of the HRVI metrics was also much lower (0.09 0.02 vs. 0.24 0.13, p 0.01).
In conclusion, similar exponential decay relationships between HRV measures and HR were seen in HCM patients with medium risk of SCD, although at different rates when compared to low risk healthy controls and high risk SCD patients. When assessed using the customized HR-based HRV adjustment approach, HCM patients had autonomic nervous dysfunction, which was manifested as reduced vagal activity and poor sympatho-vagal balance. The HRV measures with HR adjustment offer dependable and effective risk classification of SCD.
Reference:
Yan, S.-P., Song, X., Wei, L., Gong, Y.-S., Hu, H.-Y., & Li, Y.-Q. (2023). Performance of heart rate adjusted heart rate variability for risk stratification of sudden cardiac death. In BMC Cardiovascular Disorders (Vol. 23, Issue 1). Springer Science and Business Media LLC. https://doi.org/10.1186/s12872-023-03184-0
Neuroscience Masters graduate
Jacinthlyn Sylvia, a Neuroscience Master's graduate from Chennai has worked extensively in deciphering the neurobiology of cognition and motor control in aging. She also has spread-out exposure to Neurosurgery from her Bachelor’s. She is currently involved in active Neuro-Oncology research. She is an upcoming neuroscientist with a fiery passion for writing. Her news cover at Medical Dialogues feature recent discoveries and updates from the healthcare and biomedical research fields. She can be reached at editorial@medicaldialogues.in
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751